Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8934226rdf:typepubmed:Citationlld:pubmed
pubmed-article:8934226lifeskim:mentionsumls-concept:C0017296lld:lifeskim
pubmed-article:8934226lifeskim:mentionsumls-concept:C0028778lld:lifeskim
pubmed-article:8934226lifeskim:mentionsumls-concept:C0012854lld:lifeskim
pubmed-article:8934226lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:8934226lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:8934226lifeskim:mentionsumls-concept:C0205431lld:lifeskim
pubmed-article:8934226lifeskim:mentionsumls-concept:C0442335lld:lifeskim
pubmed-article:8934226pubmed:issue17lld:pubmed
pubmed-article:8934226pubmed:dateCreated1997-3-3lld:pubmed
pubmed-article:8934226pubmed:abstractTextCationic polymers can self-assemble with DNA to form polyelectrolyte complexes capable of gene delivery, although biocompatibility of the complexes is generally limited. Here we have used A-B type cationic-hydrophilic block co-polymers to introduce a protective surface hydrophilic shielding following oriented self-assembly with DNA. Block co-polymers of poly(ethylene glycol)-poly-L-lysine (pEG-pLL) and poly-N-(2-hydroxypropyl)methacrylamide-poly(trimethylammonioethyl methacrylate chloride) (pHPMA-pTMAEM) both show spontaneous formation of complexes with DNA. Surface charge measured by zeta potential is decreased compared with equivalent polycation-DNA complexes in each case. Atomic force microscopy shows that pHPMA-pTMAEM/DNA complexes are discrete spheres similar to those formed between DNA and simple polycations, whereas pEG-pLL/DNA complexes adopt an extended structure. Biological properties depend on the charge ratio of formation. At optimal charge ratio, pEG-pLL/DNA complexes show efficient transfection of 293 cells in vitro, while pHPMA-pTMAEM/DNA complexes are more inert. Both block co-polymer-DNA complexes show only limited cytotoxicity. Careful selection of block co-polymer structure can influence the physicochemical and biological properties of the complexes and should permit design of materials for specific applications, including targeted delivery of genes in vivo.lld:pubmed
pubmed-article:8934226pubmed:languageenglld:pubmed
pubmed-article:8934226pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8934226pubmed:citationSubsetIMlld:pubmed
pubmed-article:8934226pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8934226pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8934226pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8934226pubmed:statusMEDLINElld:pubmed
pubmed-article:8934226pubmed:monthNovlld:pubmed
pubmed-article:8934226pubmed:issn1043-0342lld:pubmed
pubmed-article:8934226pubmed:authorpubmed-author:UlbrichKKlld:pubmed
pubmed-article:8934226pubmed:authorpubmed-author:SchachtE HEHlld:pubmed
pubmed-article:8934226pubmed:authorpubmed-author:SeymourL WLWlld:pubmed
pubmed-article:8934226pubmed:authorpubmed-author:WolfertM AMAlld:pubmed
pubmed-article:8934226pubmed:authorpubmed-author:TonchevaVVlld:pubmed
pubmed-article:8934226pubmed:authorpubmed-author:NazarovaOOlld:pubmed
pubmed-article:8934226pubmed:issnTypePrintlld:pubmed
pubmed-article:8934226pubmed:day10lld:pubmed
pubmed-article:8934226pubmed:volume7lld:pubmed
pubmed-article:8934226pubmed:ownerNLMlld:pubmed
pubmed-article:8934226pubmed:authorsCompleteYlld:pubmed
pubmed-article:8934226pubmed:pagination2123-33lld:pubmed
pubmed-article:8934226pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8934226pubmed:meshHeadingpubmed-meshheading:8934226-...lld:pubmed
pubmed-article:8934226pubmed:meshHeadingpubmed-meshheading:8934226-...lld:pubmed
pubmed-article:8934226pubmed:meshHeadingpubmed-meshheading:8934226-...lld:pubmed
pubmed-article:8934226pubmed:meshHeadingpubmed-meshheading:8934226-...lld:pubmed
pubmed-article:8934226pubmed:meshHeadingpubmed-meshheading:8934226-...lld:pubmed
pubmed-article:8934226pubmed:meshHeadingpubmed-meshheading:8934226-...lld:pubmed
pubmed-article:8934226pubmed:meshHeadingpubmed-meshheading:8934226-...lld:pubmed
pubmed-article:8934226pubmed:meshHeadingpubmed-meshheading:8934226-...lld:pubmed
pubmed-article:8934226pubmed:meshHeadingpubmed-meshheading:8934226-...lld:pubmed
pubmed-article:8934226pubmed:meshHeadingpubmed-meshheading:8934226-...lld:pubmed
pubmed-article:8934226pubmed:meshHeadingpubmed-meshheading:8934226-...lld:pubmed
pubmed-article:8934226pubmed:meshHeadingpubmed-meshheading:8934226-...lld:pubmed
pubmed-article:8934226pubmed:meshHeadingpubmed-meshheading:8934226-...lld:pubmed
pubmed-article:8934226pubmed:meshHeadingpubmed-meshheading:8934226-...lld:pubmed
pubmed-article:8934226pubmed:meshHeadingpubmed-meshheading:8934226-...lld:pubmed
pubmed-article:8934226pubmed:year1996lld:pubmed
pubmed-article:8934226pubmed:articleTitleCharacterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymers.lld:pubmed
pubmed-article:8934226pubmed:affiliationCRC Institute for Cancer Studies, University of Birmingham, UK.lld:pubmed
pubmed-article:8934226pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8934226pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8934226lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8934226lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8934226lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8934226lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8934226lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8934226lld:pubmed